top of page
News, Events and Updates
Search
Anavex Life Sciences Provides Business Update and Reports Fiscal 2021 Third Quarter Financial Result
Aug 12, 2021
Anavex Life Sciences to Announce Fiscal 2021 3rd Quarter Financial Results on Thurs., Aug. 12, 2021
Aug 4, 2021
Anavex Life Sciences to Participate in the BTIG Virtual Biotechnology Conference 2021
Aug 3, 2021
Anavex Life Sciences Announces ANAVEX®2-73 Significantly Prevented Aβ (Abeta)-induced Deficits
Jul 28, 2021
Anavex Life Sciences Announces ANAVEX®2-73 Improved both Primary Cognitive and Second MDS-UPDRS
Jun 27, 2021
Anavex Life Sciences Announces Closing of $50 Million Registered Direct Offering
Jun 23, 2021
Anavex Life Sciences Announces $50 Million Registered Direct Offering
Jun 21, 2021
Anavex Life Sciences Announces ANAVEX®2-73 Biomarker Correlated with Efficacy Endpoint in Trial
Jun 20, 2021
Anavex Life Sciences Reports the Mechanism of ANAVEX®2-73 (blarcamesine) and ANAVEX®3-71 (AF710B)
Jun 13, 2021
12
13
14
15
16
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
